Planegg/Martinsried, March 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid ...
This week Mike and Greg discuss all the latest news from the 2025 Japan Mobility Show in Tokyo. We have new concepts and debuts from Toyota, Lexus, Mazda, Subaru, and much more. Mike also discusses ...
Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback